Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Zoledronic Acid, BMMCs, and Platelets for Early Osteonecrosis
NCT02721940Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Feb 2012
- Primary completion
- Jan 2015
- Modality
- Stem Cell Therapies, Small Molecules, Recombinant Proteins and Enzymes
01
Overview
Randomised, open-label trial of zoledronic acid, bone marrow mononuclear cells and platelets in osteonecrosis of the femoral head (ONFH), sponsored by Chinese PLA General Hospital. Primary endpoint: Magnetic resonance imaging at 18 months. Status: unknown.
02
Drugs
zoledronic acidbone marrow mononuclear cellsplatelets
03
Conditions
osteonecrosis of the femoral head (ONFH)
Beyond the preview
Go deeper on NCT02721940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02721940.